The Prospective LEUVEN Transcatheter Valve Therapy Registry
Recruiting
Observational Study
Heart Valve Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Assessment of feasibility, safety and outcomes of transcatheter valve interventions
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients selected for percutaneous treatment of a valve disorder potentially qualify for the present registry
Exclusion Criteria:
* All patients selected for percutaneous treatment of a valve disorder potentially qualify for the present registry. There are no formal excl…
Contacts